This cholesterol pill may fight high risk of heart attack, stroke: Study
An international team of researchers found that a cholesterol-lowering drug may offer a more effective and convenient way to protect people at high risk of heart attack and stroke.
The study led by researchers at Monash University in Australia tested a once-daily oral medication called Obicetrapib and found it significantly lowered both LDL or bad cholesterol and lipoprotein(a), [Lp(a)] -- two key contributors to cardiovascular disease.
The findings marked an important step forward for patients who have struggled to reach their cholesterol targets with current therapies, said study lead professor Stephen Nicholls, Director of Monash University`s Victorian Heart Institute.
"We know that many people at high risk of heart attack or stroke don`t get their cholesterol levels low enough, eve...










